| Year |
Citation |
Score |
| 2023 |
Wick C, Moghadasi SA, Becker JT, Fanunza E, Oh S, Bournique E, Buisson R, Harris RS. Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage. The Journal of Biological Chemistry. 299: 105073. PMID 37474103 DOI: 10.1016/j.jbc.2023.105073 |
0.508 |
|
| 2023 |
Jaeger AS, Crooks CM, Weiler AM, Bliss MI, Rybarczyk S, Richardson A, Einwalter M, Peterson E, Capuano S, Barkhymer A, Becker JT, Greene JT, Freedman TS, Langlois RA, Friedrich TC, et al. Primary infection with Zika virus provides one-way heterologous protection against Spondweni virus infection in rhesus macaques. Science Advances. 9: eadg3444. PMID 37390207 DOI: 10.1126/sciadv.adg3444 |
0.603 |
|
| 2023 |
Becker JT, Auerbach AA, Harris RS. APEX3 - an optimized tool for rapid and unbiased proximity labeling. Journal of Molecular Biology. 168145. PMID 37182813 DOI: 10.1016/j.jmb.2023.168145 |
0.468 |
|
| 2023 |
Manjunath L, Oh S, Ortega P, Bouin A, Bournique E, Sanchez A, Martensen PM, Auerbach AA, Becker JT, Seldin M, Harris RS, Semler BL, Buisson R. APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection. Nature Communications. 14: 820. PMID 36781883 DOI: 10.1038/s41467-023-36445-9 |
0.529 |
|
| 2022 |
Moraes SN, Becker JT, Moghadasi SA, Shaban NM, Auerbach AA, Cheng AZ, Harris RS. Evidence linking APOBEC3B genesis and evolution of innate immune antagonism by gamma-herpesvirus ribonucleotide reductases. Elife. 11. PMID 36458685 DOI: 10.7554/eLife.83893 |
0.503 |
|
| 2022 |
Auerbach AA, Becker JT, Moraes SN, Moghadasi SA, Duda JM, Salamango DJ, Harris RS. Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species. Msphere. e0045122. PMID 36374108 DOI: 10.1128/msphere.00451-22 |
0.527 |
|
| 2022 |
Moghadasi SA, Esler MA, Otsuka Y, Becker JT, Moraes SN, Anderson CB, Chamakuri S, Belica C, Wick C, Harki DA, Young DW, Scampavia L, Spicer TP, Shi K, Aihara H, et al. Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M/3CL in Living Cells. Mbio. e0078422. PMID 35471084 DOI: 10.1128/mbio.00784-22 |
0.468 |
|
| 2021 |
Benner BE, Bruce JW, Kentala JR, Murray M, Becker JT, Garcia-Miranda P, Ahlquist P, Butcher SE, Sherer NM. Perturbing HIV-1 ribosomal frameshifting frequency reveals a preference for Gag-Pol incorporation into assembling virions. Journal of Virology. JVI0134921. PMID 34643428 DOI: 10.1128/JVI.01349-21 |
0.634 |
|
| 2021 |
Knoener R, Evans E, Becker JT, Scalf M, Benner B, Sherer NM, Smith LM. Identification of host proteins differentially associated with HIV-1 RNA splice variants. Elife. 10. PMID 33629952 DOI: 10.7554/eLife.62470 |
0.675 |
|
| 2020 |
Moghadasi SA, Becker JT, Belica C, Wick C, Brown WL, Harris RS. Gain-of-function assay for SARS-CoV-2 M inhibition in living cells. Biorxiv : the Preprint Server For Biology. PMID 33200129 DOI: 10.1101/2020.11.09.375139 |
0.472 |
|
| 2020 |
Salamango DJ, McCann JL, Demir Ö, Becker JT, Wang J, Lingappa JR, Temiz NA, Brown WL, Amaro RE, Harris RS. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated using Patient HIV-1 Isolates and Computational Modeling. Journal of Virology. PMID 32847850 DOI: 10.1128/Jvi.00631-20 |
0.547 |
|
| 2019 |
Wang J, Becker JT, Shi K, Lauer KV, Salamango DJ, Aihara H, Shaban NM, Harris RS. The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H. Journal of Molecular Biology. PMID 31628948 DOI: 10.1016/J.Jmb.2019.09.014 |
0.584 |
|
| 2019 |
Wang S, Arena ET, Becker JT, Bement WM, Sherer NM, Eliceiri KW, Yuan M. Spatially Adaptive Colocalization Analysis in Dual-Color Fluorescence Microscopy. Ieee Transactions On Image Processing : a Publication of the Ieee Signal Processing Society. PMID 30951467 DOI: 10.1109/Tip.2019.2909194 |
0.585 |
|
| 2018 |
Ebrahimi D, Richards CM, Carpenter MA, Wang J, Ikeda T, Becker JT, Cheng AZ, McCann JL, Shaban NM, Salamango DJ, Starrett GJ, Lingappa JR, Yong J, Brown WL, Harris RS. Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease. Nature Communications. 9: 4137. PMID 30297863 DOI: 10.1038/S41467-018-06594-3 |
0.539 |
|
| 2018 |
Salamango DJ, Becker JT, McCann JL, Cheng AZ, Demir Ö, Amaro RE, Brown WL, Shaban NM, Harris RS. APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction. Molecular and Cellular Biology. PMID 30224517 DOI: 10.1128/Mcb.00356-18 |
0.553 |
|
| 2018 |
Evans EL, Becker JT, Fricke SL, Patel K, Sherer NM. HIV-1 Vif's capacity to manipulate the cell cycle is species-specific. Journal of Virology. PMID 29321323 DOI: 10.1128/Jvi.02102-17 |
0.674 |
|
| 2017 |
Knoener RA, Becker JT, Scalf M, Sherer NM, Smith LM. Elucidating the in vivo interactome of HIV-1 RNA by hybridization capture and mass spectrometry. Scientific Reports. 7: 16965. PMID 29208937 DOI: 10.1038/S41598-017-16793-5 |
0.684 |
|
| 2017 |
Becker JT, Sherer NM. Subcellular localization of HIV-1 gag-pol mRNAs regulates sites of virion assembly. Journal of Virology. PMID 28053097 DOI: 10.1128/Jvi.02315-16 |
0.672 |
|
| 2016 |
Garcia-Miranda P, Becker JT, Benner BE, Blume A, Sherer NM, Butcher SE. HIV frameshift site RNA stability correlates with frameshift efficiency and decreased viral infectivity. Journal of Virology. PMID 27194769 DOI: 10.1128/Jvi.00149-16 |
0.683 |
|
| 2016 |
Pocock GM, Becker JT, Swanson CM, Ahlquist P, Sherer NM. HIV-1 and M-PMV RNA Nuclear Export Elements Program Viral Genomes for Distinct Cytoplasmic Trafficking Behaviors. Plos Pathogens. 12: e1005565. PMID 27070420 DOI: 10.1371/Journal.Ppat.1005565 |
0.678 |
|
| 2015 |
Hilimire TA, Bennett RP, Stewart RA, Garcia-Miranda P, Blume A, Becker J, Sherer N, Helms ED, Butcher SE, Smith HC, Miller BL. N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA. Acs Chemical Biology. PMID 26496521 DOI: 10.1021/Acschembio.5B00682 |
0.684 |
|
| 2014 |
McNeel DG, Becker JT, Eickhoff JC, Johnson LE, Bradley E, Pohlkamp I, Staab MJ, Liu G, Wilding G, Olson BM. Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3692-704. PMID 24850844 DOI: 10.1158/1078-0432.Ccr-14-0169 |
0.578 |
|
| 2013 |
Becker JT, Eickhoff JC, Johnson LE, Liu G, Olson BM. Long-term immune responses elicited by a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with nonmetastatic castrate-resistant prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 135. PMID 28136904 DOI: 10.1200/Jco.2013.31.6_Suppl.135 |
0.361 |
|
| 2013 |
Becker JT, McNeel DG. Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination. Journal For Immunotherapy of Cancer. 1: 2. PMID 24764533 DOI: 10.1186/2051-1426-1-2 |
0.554 |
|
| 2013 |
Johnson LE, Becker JT, Dubovsky JA, Olson BM, McNeel DG. Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments. Chinese Clinical Oncology. 2. PMID 24324949 DOI: 10.3978/J.Issn.2304-3865.2012.11.06 |
0.545 |
|
| 2013 |
Lang JM, Wallace M, Becker JT, Eickhoff JC, Buehring B, Binkley N, Staab MJ, Wilding G, Liu G, Malkovsky M, McNeel DG. A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy. Clinical Genitourinary Cancer. 11: 407-15. PMID 23835291 DOI: 10.1016/J.Clgc.2013.04.029 |
0.514 |
|
| 2013 |
Casavant BP, Mosher R, Warrick JW, Maccoux LJ, Berry SM, Becker JT, Chen V, Lang JM, McNeel DG, Beebe DJ. A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells. Methods (San Diego, Calif.). 64: 137-43. PMID 23806645 DOI: 10.1016/J.Ymeth.2013.05.027 |
0.525 |
|
| 2012 |
McNeel DG, Becker JT, Johnson LE, Olson BM. DNA Vaccines for Prostate Cancer. Current Cancer Therapy Reviews. 8: 254-263. PMID 24587772 DOI: 10.2174/157339412804143113 |
0.572 |
|
| 2012 |
Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG. Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. Journal of Immunology (Baltimore, Md. : 1950). 189: 5590-601. PMID 23152566 DOI: 10.4049/Jimmunol.1201744 |
0.557 |
|
| 2012 |
Becker JT, McNeel DG. Abstract 5384: Frequency of gene allelic variants of the PAP prostate tumor antigen and association with immune response following antigen-specific genetic vaccination Cancer Research. 72: 5384-5384. DOI: 10.1158/1538-7445.Am2012-5384 |
0.58 |
|
| 2010 |
Becker JT, Olson BM, Johnson LE, Davies JG, Dunphy EJ, McNeel DG. DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 639-47. PMID 20551832 DOI: 10.1097/Cji.0B013E3181Dda23E |
0.587 |
|
| 2010 |
Becker JT, Johnson LE, McNeel DG. Abstract 5584: DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer Cancer Research. 70: 5584-5584. DOI: 10.1158/1538-7445.Am10-5584 |
0.586 |
|
| Show low-probability matches. |